Literature DB >> 10394975

Bacterial biofilms and catheters in experimental urinary tract infection.

T Goto1, Y Nakame, M Nishida, Y Ohi.   

Abstract

Employing in vitro and in vivo models of catheter-associated infection, biofilm formation of Pseudomonas aeruginosa in artificial urine and bactericidal activity of several classes alone or in combination with a macrolide antibiotic were investigated. In the course of continuous urine flow, bacteria adherent to a Teflon catheter formed microcolonies at 6 h and a biofilm at 24 h. Following 24 h of urine flow, the thickness and the density of the biofilm increased to about 20 microm and 10(8) cfu/mm3, respectively. Of the antibiotics examined, the fluoroquinolones showed the most potent bactericidal activity against the P. aeruginosa biofilms. However, those antibiotics were not always potentiated by the combination with a macrolide antibiotic.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10394975     DOI: 10.1016/s0924-8579(99)00019-9

Source DB:  PubMed          Journal:  Int J Antimicrob Agents        ISSN: 0924-8579            Impact factor:   5.283


  12 in total

1.  Interactions between biocide cationic agents and bacterial biofilms.

Authors:  C Campanac; L Pineau; A Payard; G Baziard-Mouysset; C Roques
Journal:  Antimicrob Agents Chemother       Date:  2002-05       Impact factor: 5.191

2.  Self-generated diversity produces "insurance effects" in biofilm communities.

Authors:  Blaise R Boles; Matthew Thoendel; Pradeep K Singh
Journal:  Proc Natl Acad Sci U S A       Date:  2004-11-16       Impact factor: 11.205

Review 3.  The role of biofilm infection in urology.

Authors:  P Tenke; B Kovacs; M Jäckel; E Nagy
Journal:  World J Urol       Date:  2006-01-10       Impact factor: 4.226

4.  Urinary bactericidal activity of extended-release ciprofloxacin (1,000 milligrams) versus levofloxacin (500 milligrams) in healthy volunteers receiving a single oral dose.

Authors:  Florian M E Wagenlehner; Martina Kinzig-Schippers; Uwe Tischmeyer; Christine Wagenlehner; Fritz Sörgel; Kurt G Naber
Journal:  Antimicrob Agents Chemother       Date:  2006-09-18       Impact factor: 5.191

Review 5.  Epidemiology, treatment and prevention of healthcare-associated urinary tract infections.

Authors:  F M E Wagenlehner; Mete Cek; Kurt G Naber; Hiroshi Kiyota; Truls E Bjerklund-Johansen
Journal:  World J Urol       Date:  2011-09-07       Impact factor: 4.226

6.  Susceptibility of Pseudomonas aeruginosa urinary tract isolates and influence of urinary tract conditions on antibiotic tolerance.

Authors:  Maike Narten; Nathalie Rosin; Max Schobert; Petra Tielen
Journal:  Curr Microbiol       Date:  2011-10-08       Impact factor: 2.188

7.  The role of Pseudomonas lipopolysaccharide in cystic fibrosis airway infection.

Authors:  Samuel M Moskowitz; Robert K Ernst
Journal:  Subcell Biochem       Date:  2010

Review 8.  Pharmacokinetic characteristics of antimicrobials and optimal treatment of urosepsis.

Authors:  Florian M E Wagenlehner; Wolfgang Weidner; Kurt G Naber
Journal:  Clin Pharmacokinet       Date:  2007       Impact factor: 6.447

9.  Unique lipid a modifications in Pseudomonas aeruginosa isolated from the airways of patients with cystic fibrosis.

Authors:  Robert K Ernst; Samuel M Moskowitz; Julia C Emerson; Gretchen M Kraig; Kristin N Adams; Megan D Harvey; Bonnie Ramsey; David P Speert; Jane L Burns; Samuel I Miller
Journal:  J Infect Dis       Date:  2007-08-22       Impact factor: 5.226

10.  Urinary bactericidal activity of Doripenem versus that of levofloxacin in patients with complicated urinary tract infections or pyelonephritis.

Authors:  Florian M E Wagenlehner; Christine Wagenlehner; Rebecca Redman; Wolfgang Weidner; Kurt G Naber
Journal:  Antimicrob Agents Chemother       Date:  2009-02-02       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.